$OREX Company News In focus: Breakout ... again 8:01

New Post Public Reply Private Reply Replies (0) Message Board

Sep 12, 2014 at 12:51 PM

$OREX Company News

In focus: Breakout ... again 8:01 p.m. May 28, 2014 - Lawrence G. McMillan
DaVita, Fresenius gain; energy firms slip 5:56 p.m. Nov. 25, 2013 - Ben Eisen
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen files mixed shelf for up to $150 mln 6:49 p.m. Sept. 14, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 4:43 p.m. Sept. 6, 2012 - Greg Morcroft
Orexigen soars 19% on analyst buy rating 1:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:21 p.m. Sept. 5, 2012 - MarketWatch
Orexigen weight loss study enrollment advances 8:41 a.m. Sept. 5, 2012 - MarketWatch.com
Arena jumps 12% amid takeover speculation 2:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 4:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Eisai gears up for launch of Arena's diet drug 10:32 a.m. July 30, 2012 - Val Brickates Kennedy
Vivus surges, Arena falls after diet drug OK 4:59 p.m. July 18, 2012 - Arti Patel
Arena falls 9% on FDA approval of rival diet drug 11:50 a.m. July 18, 2012 - Val Brickates Kennedy
Arena Pharmaceuticals down 8% in early trading 10:18 a.m. July 18, 2012 - Val Brickates Kennedy
Vivus up 10% on FDA approval of diet drug 10:00 a.m. July 18, 2012 - Val Brickates Kennedy
Vivus, Orexigen climb ahead of FDA decision 1:21 p.m. July 16, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:38 p.m. July 11, 2012 - MarketWatch
Orexigen has strong enrollment in Contrave study 2:42 p.m. July 11, 2012 - MarketWatch.com

Orexigen Therapeutics (OREX) Marked As A Dead Cat Bounce Stock 9:54 a.m. Today - TheStreet.com
'Fast Money' Recap: Protecting Yourself Before the Next Fed Meeting 5:00 a.m. Today - TheStreet.com
A New Nifty Fifty States Stock Index 12:46 a.m. Today - Seeking Alpha
Orexigen's Obesity Drug Contrave Approved by the FDA - Analyst Blog 4:30 p.m. Sept. 11, 2014 - Zacks.com
How Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval? 4:10 p.m. Sept. 11, 2014 - TheStreet.com
Orexigen Therapeutics' (OREX) CEO Mike Narachi Hosts Conference Call (Transcript) 3:01 p.m. Sept. 11, 2014 - Seeking Alpha
Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised 1:23 p.m. Sept. 11, 2014 - TheStreet.com
FDA Approves Weight-Loss Drug 12:50 p.m. Sept. 11, 2014 - The Wall Street Journal Interactive Edition
OREX: FDA Approves New Weight-Loss Drug Contrave 10:46 a.m. Sept. 11, 2014 - InvestorPlace.com
Weak On High Volume: Orexigen Therapeutics (OREX) 10:05 a.m. Sept. 11, 2014 - TheStreet.com
Orexigen's Contrave Approved: What It Means To Arena 10:02 a.m. Sept. 11, 2014 - Seeking Alpha
FDA Approves Orexigen's Contrave For Obesity Treatment 9:22 a.m. Sept. 11, 2014 - Seeking Alpha
Orexigen Conference Call Notes 9:02 a.m. Sept. 11, 2014 - Seeking Alpha
FDA clears Contrave 7:05 a.m. Sept. 11, 2014 - Seeking Alpha
Takeda And Orexigen Announce FDA Approval of Contrave Extended-release Tablets For Chronic Weight Management 6:01 a.m. Sept. 11, 2014 - benzinga.com
9 Analyst Stocks to Buy Under $10 With Massive Upside Potential 8:37 a.m. Sept. 6, 2014 - 247WallSt.com
Orexigen Gets Weight Loss Drug Patent, May See Runup Into Approval Decision 11:46 a.m. Sept. 5, 2014 - Seeking Alpha
Credit Suisse Positive on Some Biotechs, Very Cautious on Others 11:10 a.m. Sept. 3, 2014 - 247WallSt.com
Belviq Sales Crack Critical Level 4:46 p.m. Aug. 29, 2014 - Seeking Alpha
Vivus Acquires Patent Rights To Qsymia Ingredient 1:38 p.m. Aug. 25, 2014 - Seeking Alpha

Takeda and Orexigen Announce FDA Approval of Contrave® (naltrexone HCI and bupropion HCI) Extended-release Tablets for Chronic Weight Management 7:00 a.m. Sept. 11, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Host Conference Call and Webcast At 8:30 AM Eastern Time September 11, 2014 7:46 p.m. Sept. 10, 2014 - PR Newswire - PRF
Critical Alerts For Activision Blizzard, ACADIA Pharmaceuticals, Shutterstock, Lockheed Martin and Orexigen Therapeutics Released By InvestorsObserver 9:31 a.m. Sept. 3, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For VoxelJet, Google, Orexigen Therapeutics, Illumina, and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 8:40 a.m. July 31, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 8:00 a.m. July 31, 2014 - PR Newswire - PRF
Orexigen Receives CHMP Day 180 List of Outstanding Issues 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Critical Alerts For Regeneron Pharmaceuticals, Orexigen Therapeutics, News Corp, BorgWarner, and Michael Kors Released By InvestorsObserver 9:31 a.m. July 11, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on OPKO Health, Orexigen Therapeutics, Perrigo, and Auxilium Pharma 7:20 a.m. June 25, 2014 - PR Newswire - PRF
Clinical Studies, Review Extensions, Appointments, and Conference Schedules - Analyst Notes on Karyopharm, Orexigen, INSYS, bluebird bio and AMAG Pharmaceuticals 6:30 a.m. June 18, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Present at the Wells Fargo Securities 2014 Healthcare Conference 8:30 a.m. June 13, 2014 - PR Newswire - PRF
Critical Alerts For Apple, Orexigen Therapeutics, NextEra Energy, Family Dollar Store, and Alexion Pharmaceuticals Technology Released By InvestorsObserver 9:31 a.m. June 10, 2014 - PR Newswire - PRF
Conference Presentation Schedules, Approvals, Regulatory Updates, and Awards - Analyst Notes on St. Jude Medical, Waters, Hologic, Orexigen and USANA 6:00 a.m. June 10, 2014 - PR Newswire - PRF
Orexigen Announces June 11, 2014 PDUFA Action Date for NB32 8:00 a.m. June 2, 2014 - PR Newswire - PRF
Pre-Market Review on Top Gainers -- Research on Orexigen Therapeutics, Capstone Turbine, Magnegas, and Jumei International Holding 8:00 a.m. May 29, 2014 - PR Newswire - PRF
Milestone Payments, Clinical Trial Results, Technical Updates, and Earnings Results - Analyst Notes on Pharmacyclics, Isis, Novo Nordisk, Dr. Reddy's and Orexigen 5:10 a.m. May 29, 2014 - PR Newswire - PRF
Rejected Proposals, Earnings Results, and Financial Outlook - Analyst Notes on Allergan, Isis, Depomed, Lannett and Orexigen 7:30 a.m. May 15, 2014 - PR Newswire - PRF
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 4:30 p.m. May 9, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Crystal Risotti: Leading IT Compliance in Healthcare

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Step Inside Henson's Creature Shop Magic in NYC

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

BusyBee AI Revolutionizes Classroom Feedback Efficiency

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...